Steven Paul’s “How to improve R&D productivity: the pharmaceutical industry's grand challenge” published in Nature Reviews Drug Discovery in 2010 is one of the highest cited and most frequently quoted ...

The pharmaceutical industry has immense pressure to deliver advanced and novel therapies to patients worldwide but faces monumental challenges in drug development. On average, the journey from ...

I examine the applicability of relative R&D spending as a potential leading indicator of shareholder returns. In addition, the correlation of R&D spending with stock volatility and sales growth is ...

Paris (France), Madrid (Spain), October 3, 2014 - D&A PHARMA, a leading company in the Addiction Therapy field, is pleased to announce that it has signed an exclusive Supply, Licensing and ...

NEW YORK, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it has entered into an agreement with Biogen to provide research and development (R&D) funding of up ...

Pharma’s return on investment (ROI) for research and development (R&D) is seeing a comeback after a record low in 2022, according to a recent report out of Deloitte. ROI on pharma R&D jumped to 4.1% ...

D-Pharm Ltd (TASE: DPRM) announced today 21st January, 2015, successful completion of fundraising via a public rights issue, of 12.8M NIS in aggregate. D-Pharm's largest shareholder, CLAL ...

The biopharmaceutical industry is facing unprecedented challenges to its fundamental business model and currently cannot sustain sufficient innovation to replace its products and revenues lost due to ...

Pharmacists deliver life-changing healthcare. Their compassionate guidance educates patients on how to make the safest and best use of their prescribed medications. The University of Wyoming School of ...

Dehradun: Uttarakhand high court on Friday dismissed a batch of petitions filed by Bachelor of Pharmacy (B Pharma) holders from the state seeking eligibility for pharmacist posts that require a ...